Cayman

Showing 3301–3450 of 45550 results

  • 12:0 N-Biotinyl fatty acid is a biotinylated form of lauric acid (Item No. 10006626). It is an intermediate in the synthesis of N-biotinylated phenylarsonous acids.{47095}  

     

    Brand:
    Cayman
    SKU:25714 - 25 mg

    Available on backorder

  • 12:0 N-Biotinyl fatty acid is a biotinylated form of lauric acid (Item No. 10006626). It is an intermediate in the synthesis of N-biotinylated phenylarsonous acids.{47095}  

     

    Brand:
    Cayman
    SKU:25714 - 5 mg

    Available on backorder

  • 12(R)-HEPE is a monohydroxy fatty acid synthesized from EPA by the eggs of the sea urchin, S. purpuratus.{584} The biological activity of 12(R)-HEPE has not been extensively documented, but may be similar to that of 12(R)-HETE (Catalog No. 34560).{560,1406}  

     

    Brand:
    Cayman
    SKU:32545 - 100 µg

    Available on backorder

  • 12(R)-HEPE is a monohydroxy fatty acid synthesized from EPA by the eggs of the sea urchin, S. purpuratus.{584} The biological activity of 12(R)-HEPE has not been extensively documented, but may be similar to that of 12(R)-HETE (Catalog No. 34560).{560,1406}  

     

    Brand:
    Cayman
    SKU:32545 - 25 µg

    Available on backorder

  • 12(R)-HEPE is a monohydroxy fatty acid synthesized from EPA by the eggs of the sea urchin, S. purpuratus.{584} The biological activity of 12(R)-HEPE has not been extensively documented, but may be similar to that of 12(R)-HETE (Catalog No. 34560).{560,1406}  

     

    Brand:
    Cayman
    SKU:32545 - 50 µg

    Available on backorder

  • Biosynthesis of 12(R)-HETE in invertebrates is via lipoxygenation of arachidonic acid (Item No. 90010).{584} In mammals, 12(R)-HETE can be produced by 12(R)-LOs and also by CYP450 oxidation.{559,562} The activity of 12(R)-HETE in mammals is predominantly proinflammatory.{559} 12(R)-HETE exhibits dose-dependent leukocyte chemotaxis at concentrations as low as 100 nM, and lowers intraocular pressure in rabbits.  

     

    Brand:
    Cayman
    SKU:34560 - 100 µg

    Available on backorder

  • Biosynthesis of 12(R)-HETE in invertebrates is via lipoxygenation of arachidonic acid (Item No. 90010).{584} In mammals, 12(R)-HETE can be produced by 12(R)-LOs and also by CYP450 oxidation.{559,562} The activity of 12(R)-HETE in mammals is predominantly proinflammatory.{559} 12(R)-HETE exhibits dose-dependent leukocyte chemotaxis at concentrations as low as 100 nM, and lowers intraocular pressure in rabbits.  

     

    Brand:
    Cayman
    SKU:34560 - 25 µg

    Available on backorder

  • Biosynthesis of 12(R)-HETE in invertebrates is via lipoxygenation of arachidonic acid (Item No. 90010).{584} In mammals, 12(R)-HETE can be produced by 12(R)-LOs and also by CYP450 oxidation.{559,562} The activity of 12(R)-HETE in mammals is predominantly proinflammatory.{559} 12(R)-HETE exhibits dose-dependent leukocyte chemotaxis at concentrations as low as 100 nM, and lowers intraocular pressure in rabbits.  

     

    Brand:
    Cayman
    SKU:34560 - 50 µg

    Available on backorder

  • 12(S)-HEPE is a monohydroxy fatty acid synthesized from EPA by the action of 12-LO. Unstimulated neutrophils metabolize 12(S)-HEPE to 12(S),20-diHEPE, whereas stimulated neutrophils produce 5(S),12(S)-HEPE via the 5-lipoxygenase pathway.{6402} The competitive action of 12(S)-HEPE with arachidonic acid as a substrate for 5-LO in the formation of leukotrienes may provide a basis for the anti-inflammatory potential of ω-3 fatty acids.  

     

    Brand:
    Cayman
    SKU:32550 - 100 µg

    Available on backorder

  • 12(S)-HEPE is a monohydroxy fatty acid synthesized from EPA by the action of 12-LO. Unstimulated neutrophils metabolize 12(S)-HEPE to 12(S),20-diHEPE, whereas stimulated neutrophils produce 5(S),12(S)-HEPE via the 5-lipoxygenase pathway.{6402} The competitive action of 12(S)-HEPE with arachidonic acid as a substrate for 5-LO in the formation of leukotrienes may provide a basis for the anti-inflammatory potential of ω-3 fatty acids.  

     

    Brand:
    Cayman
    SKU:32550 - 25 µg

    Available on backorder

  • 12(S)-HEPE is a monohydroxy fatty acid synthesized from EPA by the action of 12-LO. Unstimulated neutrophils metabolize 12(S)-HEPE to 12(S),20-diHEPE, whereas stimulated neutrophils produce 5(S),12(S)-HEPE via the 5-lipoxygenase pathway.{6402} The competitive action of 12(S)-HEPE with arachidonic acid as a substrate for 5-LO in the formation of leukotrienes may provide a basis for the anti-inflammatory potential of ω-3 fatty acids.  

     

    Brand:
    Cayman
    SKU:32550 - 50 µg

    Available on backorder

  • 12(S)-HETE is the predominant lipoxygenase product of mammalian platelets.{498} It enhances tumor cell adhesion to endothelial cells, fibronectin, and the subendothelial matrix at 0.1 µM.{591,880}  

     

    Brand:
    Cayman
    SKU:34570 - 100 µg

    Available on backorder

  • 12(S)-HETE is the predominant lipoxygenase product of mammalian platelets.{498} It enhances tumor cell adhesion to endothelial cells, fibronectin, and the subendothelial matrix at 0.1 µM.{591,880}  

     

    Brand:
    Cayman
    SKU:34570 - 25 µg

    Available on backorder

  • 12(S)-HETE is the predominant lipoxygenase product of mammalian platelets.{498} It enhances tumor cell adhesion to endothelial cells, fibronectin, and the subendothelial matrix at 0.1 µM.{591,880}  

     

    Brand:
    Cayman
    SKU:34570 - 50 µg

    Available on backorder

  • 12(S)-HETE is the predominant lipoxygenase product of mammalian platelets.{498} It enhances tumor cell adhesion to endothelial cells, fibronectin, and the subendothelial matrix at 0.1 µM.{591,880} 12(S)-HETE MaxSpec® standard is a quantitative grade standard of 12(S)-HETE (Item No. 34570) that has been prepared specifically for mass spectrometry or any application where quantitative reproducibility is required. The solution has been prepared gravimetrically and is supplied in a deactivated glass ampule sealed under argon. The concentration was verified by comparison to an independently prepared calibration standard. This 12(S)-HETE MaxSpec® standard is guaranteed to meet identity, purity, stability, and concentration specifications and is provided with a batch-specific certificate of analysis. Ongoing stability testing is performed to ensure the concentration remains accurate throughout the shelf life of the product. Note: The amount of solution added to the vial is in excess of the listed amount. Therefore, it is necessary to accurately measure volumes for preparation of calibration standards. Follow recommended storage and handling conditions to maintain product quality.  

     

    Brand:
    Cayman
    SKU:10007248 - 10 µg

    Available on backorder

  • 12(S)-HETE-d8 contains eight deuterium atoms at the 5, 6, 8, 9, 11, 12, 14 and 15 positions. It is intended for use as an internal standard for the quantification of 12(S)-HETE by GC- or LC-mass spectrometry (MS). 12(S)-HETE is the predominant lipoxygenase product of mammalian platelets.{498} It enhances tumor cell adhesion to endothelial cells, fibronectin, and the subendothelial matrix at 0.1 µM.{591,880}  

     

    Brand:
    Cayman
    SKU:334570 - 100 µg

    Available on backorder

  • 12(S)-HETE-d8 contains eight deuterium atoms at the 5, 6, 8, 9, 11, 12, 14 and 15 positions. It is intended for use as an internal standard for the quantification of 12(S)-HETE by GC- or LC-mass spectrometry (MS). 12(S)-HETE is the predominant lipoxygenase product of mammalian platelets.{498} It enhances tumor cell adhesion to endothelial cells, fibronectin, and the subendothelial matrix at 0.1 µM.{591,880}  

     

    Brand:
    Cayman
    SKU:334570 - 25 µg

    Available on backorder

  • 12(S)-HETE-d8 contains eight deuterium atoms at the 5, 6, 8, 9, 11, 12, 14 and 15 positions. It is intended for use as an internal standard for the quantification of 12(S)-HETE by GC- or LC-mass spectrometry (MS). 12(S)-HETE is the predominant lipoxygenase product of mammalian platelets.{498} It enhances tumor cell adhesion to endothelial cells, fibronectin, and the subendothelial matrix at 0.1 µM.{591,880}  

     

    Brand:
    Cayman
    SKU:334570 - 50 µg

    Available on backorder

  • 12(S)-HETrE is produced by 12-lipoxygenase oxidation of dihomo-γ-linolenic acid (DGLA).{31110} 12(S)-HETrE is reported to inhibit agonist-mediated platelet activation (IC50 = 40 µM), α granule secretion, integrin αIIbβ3 activation, Rap1 activation, and thrombin-induced clot retraction in vitro.{31110}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • 12(S)-HETrE is produced by 12-lipoxygenase oxidation of dihomo-γ-linolenic acid (DGLA).{31110} 12(S)-HETrE is reported to inhibit agonist-mediated platelet activation (IC50 = 40 µM), α granule secretion, integrin αIIbβ3 activation, Rap1 activation, and thrombin-induced clot retraction in vitro.{31110}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • 12(S)-HETrE is produced by 12-lipoxygenase oxidation of dihomo-γ-linolenic acid (DGLA).{31110} 12(S)-HETrE is reported to inhibit agonist-mediated platelet activation (IC50 = 40 µM), α granule secretion, integrin αIIbβ3 activation, Rap1 activation, and thrombin-induced clot retraction in vitro.{31110}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • 12(S)-HETrE is produced by 12-lipoxygenase oxidation of dihomo-γ-linolenic acid (DGLA).{31110} 12(S)-HETrE is reported to inhibit agonist-mediated platelet activation (IC50 = 40 µM), α granule secretion, integrin αIIbβ3 activation, Rap1 activation, and thrombin-induced clot retraction in vitro.{31110}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • 12(S)-HHTrE is a product of the cyclooxygenase (COX) pathway and one of the primary arachidonic acid metabolites of human platelets.{567} It is biosynthesized by thromboxane (TXA2) synthase from prostaglandin H2 (PGH2) concurrently with TXA2. 12(S)-HHTrE is a natural lipid agonist of the leukotriene B2 receptor BLT2 in vivo that induces chemotaxis of mast cells and accelerates wound closure.{15587,26266} 12(S)-HHTrE is avidly oxidized to 12-oxoHTrE by porcine 15-hydroxy PGDH.{566}  

     

    Brand:
    Cayman
    SKU:34590 - 100 µg

    Available on backorder

  • 12(S)-HHTrE is a product of the cyclooxygenase (COX) pathway and one of the primary arachidonic acid metabolites of human platelets.{567} It is biosynthesized by thromboxane (TXA2) synthase from prostaglandin H2 (PGH2) concurrently with TXA2. 12(S)-HHTrE is a natural lipid agonist of the leukotriene B2 receptor BLT2 in vivo that induces chemotaxis of mast cells and accelerates wound closure.{15587,26266} 12(S)-HHTrE is avidly oxidized to 12-oxoHTrE by porcine 15-hydroxy PGDH.{566}  

     

    Brand:
    Cayman
    SKU:34590 - 25 µg

    Available on backorder

  • 12(S)-HHTrE is a product of the cyclooxygenase (COX) pathway and one of the primary arachidonic acid metabolites of human platelets.{567} It is biosynthesized by thromboxane (TXA2) synthase from prostaglandin H2 (PGH2) concurrently with TXA2. 12(S)-HHTrE is a natural lipid agonist of the leukotriene B2 receptor BLT2 in vivo that induces chemotaxis of mast cells and accelerates wound closure.{15587,26266} 12(S)-HHTrE is avidly oxidized to 12-oxoHTrE by porcine 15-hydroxy PGDH.{566}  

     

    Brand:
    Cayman
    SKU:34590 - 250 µg

    Available on backorder

  • 12(S)-HHTrE is a product of the cyclooxygenase (COX) pathway and one of the primary arachidonic acid metabolites of human platelets.{567} It is biosynthesized by thromboxane (TXA2) synthase from prostaglandin H2 (PGH2) concurrently with TXA2. 12(S)-HHTrE is a natural lipid agonist of the leukotriene B2 receptor BLT2 in vivo that induces chemotaxis of mast cells and accelerates wound closure.{15587,26266} 12(S)-HHTrE is avidly oxidized to 12-oxoHTrE by porcine 15-hydroxy PGDH.{566}  

     

    Brand:
    Cayman
    SKU:34590 - 50 µg

    Available on backorder

  • 12(S)-HpEPE is a monohydroperoxy polyunsaturated fatty acid produced by the action of 12-lipoxygenase on eicosapentaenoic acid. Although the biological activities of 12(S)-HpEPE have not been well characterized, it is expected to behave similarly to 12(S)-HpETE (Catalog No. 44570).  

     

    Brand:
    Cayman
    SKU:42550 - 100 µg

    Available on backorder

  • 12(S)-HpEPE is a monohydroperoxy polyunsaturated fatty acid produced by the action of 12-lipoxygenase on eicosapentaenoic acid. Although the biological activities of 12(S)-HpEPE have not been well characterized, it is expected to behave similarly to 12(S)-HpETE (Catalog No. 44570).  

     

    Brand:
    Cayman
    SKU:42550 - 25 µg

    Available on backorder

  • 12(S)-HpEPE is a monohydroperoxy polyunsaturated fatty acid produced by the action of 12-lipoxygenase on eicosapentaenoic acid. Although the biological activities of 12(S)-HpEPE have not been well characterized, it is expected to behave similarly to 12(S)-HpETE (Catalog No. 44570).  

     

    Brand:
    Cayman
    SKU:42550 - 50 µg

    Available on backorder

  • 12(S)-HpETE is a monohydroperoxy polyunsaturated fatty acid (PUFA) produced by the action of platelet or leukocyte 12-lipoxygenase (12-LO) on arachidonic acid.{452,3959} It activates human blood leukocyte 5-LO, resulting in the synthesis of 5(S)-HETE, leukotriene B4 (LTB4), and 5(S),12(S)-DiHETE.{452} Rat lung metabolizes 12(S)-HpETE to 8,11,12- and 10,11,12-trihydroxyeicostrienoic acids.{194} 12(S)-HpETE is the mediator of many biological functions, including induction of c-fos and c-jun, activation of AP-1, and endothelium-dependent vasoconstriction.{6182,4194} It mediates the inhibitory synaptic response to FMRF-amide in Aplysia sensory neurons{624} and inhibits Ca2+/calmodulin-dependent protein kinase II from rat brain cortex.{2366,624}  

     

    Brand:
    Cayman
    SKU:44570 - 100 µg

    Available on backorder

  • 12(S)-HpETE is a monohydroperoxy polyunsaturated fatty acid (PUFA) produced by the action of platelet or leukocyte 12-lipoxygenase (12-LO) on arachidonic acid.{452,3959} It activates human blood leukocyte 5-LO, resulting in the synthesis of 5(S)-HETE, leukotriene B4 (LTB4), and 5(S),12(S)-DiHETE.{452} Rat lung metabolizes 12(S)-HpETE to 8,11,12- and 10,11,12-trihydroxyeicostrienoic acids.{194} 12(S)-HpETE is the mediator of many biological functions, including induction of c-fos and c-jun, activation of AP-1, and endothelium-dependent vasoconstriction.{6182,4194} It mediates the inhibitory synaptic response to FMRF-amide in Aplysia sensory neurons{624} and inhibits Ca2+/calmodulin-dependent protein kinase II from rat brain cortex.{2366,624}  

     

    Brand:
    Cayman
    SKU:44570 - 25 µg

    Available on backorder

  • 12(S)-HpETE is a monohydroperoxy polyunsaturated fatty acid (PUFA) produced by the action of platelet or leukocyte 12-lipoxygenase (12-LO) on arachidonic acid.{452,3959} It activates human blood leukocyte 5-LO, resulting in the synthesis of 5(S)-HETE, leukotriene B4 (LTB4), and 5(S),12(S)-DiHETE.{452} Rat lung metabolizes 12(S)-HpETE to 8,11,12- and 10,11,12-trihydroxyeicostrienoic acids.{194} 12(S)-HpETE is the mediator of many biological functions, including induction of c-fos and c-jun, activation of AP-1, and endothelium-dependent vasoconstriction.{6182,4194} It mediates the inhibitory synaptic response to FMRF-amide in Aplysia sensory neurons{624} and inhibits Ca2+/calmodulin-dependent protein kinase II from rat brain cortex.{2366,624}  

     

    Brand:
    Cayman
    SKU:44570 - 250 µg

    Available on backorder

  • 12(S)-HpETE is a monohydroperoxy polyunsaturated fatty acid (PUFA) produced by the action of platelet or leukocyte 12-lipoxygenase (12-LO) on arachidonic acid.{452,3959} It activates human blood leukocyte 5-LO, resulting in the synthesis of 5(S)-HETE, leukotriene B4 (LTB4), and 5(S),12(S)-DiHETE.{452} Rat lung metabolizes 12(S)-HpETE to 8,11,12- and 10,11,12-trihydroxyeicostrienoic acids.{194} 12(S)-HpETE is the mediator of many biological functions, including induction of c-fos and c-jun, activation of AP-1, and endothelium-dependent vasoconstriction.{6182,4194} It mediates the inhibitory synaptic response to FMRF-amide in Aplysia sensory neurons{624} and inhibits Ca2+/calmodulin-dependent protein kinase II from rat brain cortex.{2366,624}  

     

    Brand:
    Cayman
    SKU:44570 - 50 µg

    Available on backorder

  • 12(S)-hydroxy-16-Heptadecynoic acid is a mechanism-based inhibitor of cytochrome P450 ω-hydroxylase.{1051} It inhibits prostaglandin ω-hydroxylase with a Ki value of 1.8 µM.{1051}  

     

    Brand:
    Cayman
    SKU:31570 - 1 mg

    Available on backorder

  • 12(S)-hydroxy-16-Heptadecynoic acid is a mechanism-based inhibitor of cytochrome P450 ω-hydroxylase.{1051} It inhibits prostaglandin ω-hydroxylase with a Ki value of 1.8 µM.{1051}  

     

    Brand:
    Cayman
    SKU:31570 - 10 mg

    Available on backorder

  • 12(S)-hydroxy-16-Heptadecynoic acid is a mechanism-based inhibitor of cytochrome P450 ω-hydroxylase.{1051} It inhibits prostaglandin ω-hydroxylase with a Ki value of 1.8 µM.{1051}  

     

    Brand:
    Cayman
    SKU:31570 - 5 mg

    Available on backorder

  • 12(Z),15(Z)-Heneicosadienoic acid is an ω-6 very long-chain polyunsaturated fatty acid. It is a positional isomer of heneicosadienoic acid (Item No. 22593) that is rare in living organisms.{39308}  

     

    Brand:
    Cayman
    SKU:22594 -

    Out of stock

  • 12(Z),15(Z)-Heneicosadienoic acid is an ω-6 very long-chain polyunsaturated fatty acid. It is a positional isomer of heneicosadienoic acid (Item No. 22593) that is rare in living organisms.{39308}  

     

    Brand:
    Cayman
    SKU:22594 -

    Out of stock

  • 12(Z),15(Z)-Heneicosadienoic acid is an ω-6 very long-chain polyunsaturated fatty acid. It is a positional isomer of heneicosadienoic acid (Item No. 22593) that is rare in living organisms.{39308}  

     

    Brand:
    Cayman
    SKU:22594 -

    Out of stock

  • 1233B is a fungal metabolite and an open-ring derivative of L-659,699 (hymeglusin; Item No. 11899) that lacks HMG-CoA synthase inhibitory activity.{49098,21712}  

     

    Brand:
    Cayman
    SKU:27712 - 1 mg

    Available on backorder

  • 1233B is a fungal metabolite and an open-ring derivative of L-659,699 (hymeglusin; Item No. 11899) that lacks HMG-CoA synthase inhibitory activity.{49098,21712}  

     

    Brand:
    Cayman
    SKU:27712 - 500 µg

    Available on backorder

  • 13-acetyl-9-Dihydrobaccatin III is a taxane originally isolated from T. canadensis.{54042} It inhibits proliferation of P388 leukemia cells with an IC50 value of 20 μg/ml.  

     

    Brand:
    Cayman
    SKU:29701 - 1 mg

    Available on backorder

  • 13-acetyl-9-Dihydrobaccatin III is a taxane originally isolated from T. canadensis.{54042} It inhibits proliferation of P388 leukemia cells with an IC50 value of 20 μg/ml.  

     

    Brand:
    Cayman
    SKU:29701 - 10 mg

    Available on backorder

  • 13-acetyl-9-Dihydrobaccatin III is a taxane originally isolated from T. canadensis.{54042} It inhibits proliferation of P388 leukemia cells with an IC50 value of 20 μg/ml.  

     

    Brand:
    Cayman
    SKU:29701 - 5 mg

    Available on backorder

  • 13-cis Retinoic acid-d5 is intended for use as an internal standard for the quantification of 13-cis retinoic acid by GC- or LC-MS. 13-cis Retinoic acid is a naturally occurring retinoid that inhibits retinol oxidation and dehydrogenation of 17β-hydroxy steroids.{40199}  

     

    Brand:
    Cayman
    SKU:21855 -

    Out of stock

  • 13-Docosenamide is the amide of docosenoic acid. It was first identified in the cerebrospinal fluid of sleep-deprived cats. It has also been detected in the cerebrospinal fluid of rats and humans.{1317} 13-Docosenamide causes reduced mobility and slightly lessened awareness in rats, whereas 9-octadecenamide induces physiological sleep.  

     

    Brand:
    Cayman
    SKU:90377 - 1 g

    Available on backorder

  • 13-Docosenamide is the amide of docosenoic acid. It was first identified in the cerebrospinal fluid of sleep-deprived cats. It has also been detected in the cerebrospinal fluid of rats and humans.{1317} 13-Docosenamide causes reduced mobility and slightly lessened awareness in rats, whereas 9-octadecenamide induces physiological sleep.  

     

    Brand:
    Cayman
    SKU:90377 - 5 g

    Available on backorder

  • 13-epi-12-oxo Phytodienoic acid (13-epi-12-oxo PDA) is a lipoxygenase metabolite of α-linolenic acid in the leaves of green plants such as corn. ω-3 and ω-6 polyunsaturated fatty acids in plants are substrates for plant lipoxygenases.{857} 12-oxo PDA is one of the best studied end metabolites of this enzymatic pathway.{1562} While the initial enzymatic product and major isomer of 12-oxo PDA contains side chains in the cis position, both being β to the ring, the upper side chain attached at C-13, can and frequently does, isomerize when 12-oxo PDA is extracted, isolated, or stored. 13-epi-12-oxo PDA is the product of this isomerization.  

     

    Brand:
    Cayman
    SKU:10195 - 1 mg

    Available on backorder

  • 13-epi-12-oxo Phytodienoic acid (13-epi-12-oxo PDA) is a lipoxygenase metabolite of α-linolenic acid in the leaves of green plants such as corn. ω-3 and ω-6 polyunsaturated fatty acids in plants are substrates for plant lipoxygenases.{857} 12-oxo PDA is one of the best studied end metabolites of this enzymatic pathway.{1562} While the initial enzymatic product and major isomer of 12-oxo PDA contains side chains in the cis position, both being β to the ring, the upper side chain attached at C-13, can and frequently does, isomerize when 12-oxo PDA is extracted, isolated, or stored. 13-epi-12-oxo PDA is the product of this isomerization.  

     

    Brand:
    Cayman
    SKU:10195 - 100 µg

    Available on backorder

  • 13-epi-12-oxo Phytodienoic acid (13-epi-12-oxo PDA) is a lipoxygenase metabolite of α-linolenic acid in the leaves of green plants such as corn. ω-3 and ω-6 polyunsaturated fatty acids in plants are substrates for plant lipoxygenases.{857} 12-oxo PDA is one of the best studied end metabolites of this enzymatic pathway.{1562} While the initial enzymatic product and major isomer of 12-oxo PDA contains side chains in the cis position, both being β to the ring, the upper side chain attached at C-13, can and frequently does, isomerize when 12-oxo PDA is extracted, isolated, or stored. 13-epi-12-oxo PDA is the product of this isomerization.  

     

    Brand:
    Cayman
    SKU:10195 - 500 µg

    Available on backorder

  • 13-methyl Myristic acid is a methylated fatty acid that has been found in dairy ewe rumen liquor, bovine milk, goat milk fat, the edible flesh of rainbow trout (O. mykiss), and Flavobacterium.{39687,39688,39689,39690,39691} 13-methyl Myristic acid is also found in arable soil, and its levels decrease in response to contamination with the heavy metals cadmium, copper, nickel, and lead.{39692} [Matreya, LLC. Catalog No. 1605]  

     

    Brand:
    Cayman
    SKU:24811 - 10 mg

    Available on backorder

  • 13-methyl Myristic acid is a methylated fatty acid that has been found in dairy ewe rumen liquor, bovine milk, goat milk fat, the edible flesh of rainbow trout (O. mykiss), and Flavobacterium.{39687,39688,39689,39690,39691} 13-methyl Myristic acid is also found in arable soil, and its levels decrease in response to contamination with the heavy metals cadmium, copper, nickel, and lead.{39692} [Matreya, LLC. Catalog No. 1605]  

     

    Brand:
    Cayman
    SKU:24811 - 25 mg

    Available on backorder

  • 13-methyl Myristic acid is a methylated fatty acid that has been found in dairy ewe rumen liquor, bovine milk, goat milk fat, the edible flesh of rainbow trout (O. mykiss), and Flavobacterium.{39687,39688,39689,39690,39691} 13-methyl Myristic acid is also found in arable soil, and its levels decrease in response to contamination with the heavy metals cadmium, copper, nickel, and lead.{39692} [Matreya, LLC. Catalog No. 1605]  

     

    Brand:
    Cayman
    SKU:24811 - 5 mg

    Available on backorder

  • 13-methyl Myristic acid methyl ester is a methylated bacterial fatty acid methyl ester.{39693,39694} It has been used as a marker of bacteria in sewage sludges and of bacterial contaminants in pharmaceutical manufacturing by GC-MS.{39695,39696} [Matreya, LLC. Catalog No. 1600]  

     

    Brand:
    Cayman
    SKU:24812 - 10 mg

    Available on backorder

  • 13-methyl Myristic acid methyl ester is a methylated bacterial fatty acid methyl ester.{39693,39694} It has been used as a marker of bacteria in sewage sludges and of bacterial contaminants in pharmaceutical manufacturing by GC-MS.{39695,39696} [Matreya, LLC. Catalog No. 1600]  

     

    Brand:
    Cayman
    SKU:24812 - 25 mg

    Available on backorder

  • 13-methyl Pentadecanoic acid methyl ester is a methylated fatty acid methyl ester that has been found in the bioactive fraction of A. malabarica extract, C. variabilis microalgae, and baboon liver.{39697,40927,39698} [Matreya, LLC. Catalog No. 1613]  

     

    Brand:
    Cayman
    SKU:24819 - 10 mg

    Available on backorder

  • 13-methyl Pentadecanoic acid methyl ester is a methylated fatty acid methyl ester that has been found in the bioactive fraction of A. malabarica extract, C. variabilis microalgae, and baboon liver.{39697,40927,39698} [Matreya, LLC. Catalog No. 1613]  

     

    Brand:
    Cayman
    SKU:24819 - 25 mg

    Available on backorder

  • 13-methyl Pentadecanoic acid methyl ester is a methylated fatty acid methyl ester that has been found in the bioactive fraction of A. malabarica extract, C. variabilis microalgae, and baboon liver.{39697,40927,39698} [Matreya, LLC. Catalog No. 1613]  

     

    Brand:
    Cayman
    SKU:24819 - 5 mg

    Available on backorder

  • 13-Methylberberine (13-MB) (chloride) is a 13-methyl-substituted derivative of berberine (Item No. 10006427). Berberine is a widely distributed berberidaceaen alkaloid found in plant tissues that has antibacterial, anti-inflammatory, antitumor, anti-obesity, and hypercholesterolemic activity.{32930,12390} 13-MB has improved antibacterial activity against S. aureus (MIC = 125 µg/ml) and improved antitumor activity with a mean GI50 value of 11.7 µM, as compared to berberine.{37022,37023,37024} 13-MB also induces down-regulation of adipocyte differentiation transcription factors, reduces de novo lipid synthesis, and accumulates in murine 3T3-L1 adipocytes at higher levels than berberine, suggesting improved anti-obesity activity.{32930}  

     

    Brand:
    Cayman
    SKU:21154 -

    Out of stock

  • 13-Methylberberine (13-MB) (chloride) is a 13-methyl-substituted derivative of berberine (Item No. 10006427). Berberine is a widely distributed berberidaceaen alkaloid found in plant tissues that has antibacterial, anti-inflammatory, antitumor, anti-obesity, and hypercholesterolemic activity.{32930,12390} 13-MB has improved antibacterial activity against S. aureus (MIC = 125 µg/ml) and improved antitumor activity with a mean GI50 value of 11.7 µM, as compared to berberine.{37022,37023,37024} 13-MB also induces down-regulation of adipocyte differentiation transcription factors, reduces de novo lipid synthesis, and accumulates in murine 3T3-L1 adipocytes at higher levels than berberine, suggesting improved anti-obesity activity.{32930}  

     

    Brand:
    Cayman
    SKU:21154 -

    Out of stock

  • 13-Methylberberine (13-MB) (chloride) is a 13-methyl-substituted derivative of berberine (Item No. 10006427). Berberine is a widely distributed berberidaceaen alkaloid found in plant tissues that has antibacterial, anti-inflammatory, antitumor, anti-obesity, and hypercholesterolemic activity.{32930,12390} 13-MB has improved antibacterial activity against S. aureus (MIC = 125 µg/ml) and improved antitumor activity with a mean GI50 value of 11.7 µM, as compared to berberine.{37022,37023,37024} 13-MB also induces down-regulation of adipocyte differentiation transcription factors, reduces de novo lipid synthesis, and accumulates in murine 3T3-L1 adipocytes at higher levels than berberine, suggesting improved anti-obesity activity.{32930}  

     

    Brand:
    Cayman
    SKU:21154 -

    Out of stock

  • 13-oxoODE is produced from 13-HODE by a NAD+-dependent dehydrogenase present in rat colonic mucosa.{184} 13-OxoODE stimulates cell proliferation when instilled intrarectally in rats.{2210} 13-OxoODE has also been detected in preparations of rabbit reticulocyte plasma and mitochondrial membranes, mostly esterified to phospholipids. Production of 13-oxoODE is putatively linked to the maturation of reticulocytes to erythrocytes through the activity of 15-LO.{2261,2262}  

     

    Brand:
    Cayman
    SKU:38620 - 100 µg

    Available on backorder

  • 13-oxoODE is produced from 13-HODE by a NAD+-dependent dehydrogenase present in rat colonic mucosa.{184} 13-OxoODE stimulates cell proliferation when instilled intrarectally in rats.{2210} 13-OxoODE has also been detected in preparations of rabbit reticulocyte plasma and mitochondrial membranes, mostly esterified to phospholipids. Production of 13-oxoODE is putatively linked to the maturation of reticulocytes to erythrocytes through the activity of 15-LO.{2261,2262}  

     

    Brand:
    Cayman
    SKU:38620 - 25 µg

    Available on backorder

  • 13-oxoODE is produced from 13-HODE by a NAD+-dependent dehydrogenase present in rat colonic mucosa.{184} 13-OxoODE stimulates cell proliferation when instilled intrarectally in rats.{2210} 13-OxoODE has also been detected in preparations of rabbit reticulocyte plasma and mitochondrial membranes, mostly esterified to phospholipids. Production of 13-oxoODE is putatively linked to the maturation of reticulocytes to erythrocytes through the activity of 15-LO.{2261,2262}  

     

    Brand:
    Cayman
    SKU:38620 - 50 µg

    Available on backorder

  • 13,14-dehydro-15-cyclohexyl Carbaprostacyclin is a chemically stable analog of PGI2. It inhibits the ADP-induced aggregation of human platelets with an ED50 of about 40 nM in PRP and 77 nM in washed platelets, which is comparable to the potency of carbaprostacyclin.{1272,1283}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • 13,14-dehydro-15-cyclohexyl Carbaprostacyclin is a chemically stable analog of PGI2. It inhibits the ADP-induced aggregation of human platelets with an ED50 of about 40 nM in PRP and 77 nM in washed platelets, which is comparable to the potency of carbaprostacyclin.{1272,1283}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • 13,14-dehydro-15-cyclohexyl Carbaprostacyclin is a chemically stable analog of PGI2. It inhibits the ADP-induced aggregation of human platelets with an ED50 of about 40 nM in PRP and 77 nM in washed platelets, which is comparable to the potency of carbaprostacyclin.{1272,1283}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • 13,14-dihydro Prostaglandin E1 (13,14-dihydro PGE1) is a biologically active metabolite of PGE1 with comparable potency to the parent compound.{4168,182} It is an inhibitor of ADP-induced platelet aggregation in human PRP and washed platelets with IC50 values of 31 and 21 nM, respectively.{1607} 13,14-dihydro PGE1 is a slightly more potent inhibitor of ADP-induced human platelet aggregation than PGE1 (Item No. 13010) which has an IC50 value of 40 nM.{960} Also, 13,14-dihydro PGE1 was shown to activate adenylate cyclase in NCB-20 hybrid cells with a Kact value of 668 nM.{1926}  

     

    Brand:
    Cayman
    SKU:-
  • 13,14-dihydro Prostaglandin E1 (13,14-dihydro PGE1) is a biologically active metabolite of PGE1 with comparable potency to the parent compound.{4168,182} It is an inhibitor of ADP-induced platelet aggregation in human PRP and washed platelets with IC50 values of 31 and 21 nM, respectively.{1607} 13,14-dihydro PGE1 is a slightly more potent inhibitor of ADP-induced human platelet aggregation than PGE1 (Item No. 13010) which has an IC50 value of 40 nM.{960} Also, 13,14-dihydro PGE1 was shown to activate adenylate cyclase in NCB-20 hybrid cells with a Kact value of 668 nM.{1926}  

     

    Brand:
    Cayman
    SKU:-
  • 13,14-dihydro Prostaglandin E1 (13,14-dihydro PGE1) is a biologically active metabolite of PGE1 with comparable potency to the parent compound.{4168,182} It is an inhibitor of ADP-induced platelet aggregation in human PRP and washed platelets with IC50 values of 31 and 21 nM, respectively.{1607} 13,14-dihydro PGE1 is a slightly more potent inhibitor of ADP-induced human platelet aggregation than PGE1 (Item No. 13010) which has an IC50 value of 40 nM.{960} Also, 13,14-dihydro PGE1 was shown to activate adenylate cyclase in NCB-20 hybrid cells with a Kact value of 668 nM.{1926}  

     

    Brand:
    Cayman
    SKU:-
  • 13,14-dihydro Prostaglandin E1 (13,14-dihydro PGE1) is a biologically active metabolite of PGE1 with comparable potency to the parent compound.{4168,182} It is an inhibitor of ADP-induced platelet aggregation in human PRP and washed platelets with IC50 values of 31 and 21 nM, respectively.{1607} 13,14-dihydro PGE1 is a slightly more potent inhibitor of ADP-induced human platelet aggregation than PGE1 (Item No. 13010) which has an IC50 value of 40 nM.{960} Also, 13,14-dihydro PGE1 was shown to activate adenylate cyclase in NCB-20 hybrid cells with a Kact value of 668 nM.{1926}  

     

    Brand:
    Cayman
    SKU:-
  • 13,14-dihydro PGF1α is a potential metabolite of PGF1α.{2346} Its biological activity has not been reported. The corresponding compound in the E1 series (13,14-dihydro PGE1) retains biological activity similar to PGE1.{4168}  

     

    Brand:
    Cayman
    SKU:-
  • 13,14-dihydro PGF1α is a potential metabolite of PGF1α.{2346} Its biological activity has not been reported. The corresponding compound in the E1 series (13,14-dihydro PGE1) retains biological activity similar to PGE1.{4168}  

     

    Brand:
    Cayman
    SKU:-
  • 13,14-dihydro PGF1α is a potential metabolite of PGF1α.{2346} Its biological activity has not been reported. The corresponding compound in the E1 series (13,14-dihydro PGE1) retains biological activity similar to PGE1.{4168}  

     

    Brand:
    Cayman
    SKU:-
  • 13,14-dihydro Prostaglandin F2α (13,14-dihydro PGF2α) is the analog of PGF2α which has no unsaturation in the lower side chain. It causes luteolysis in hamsters with a potency five times higher than PGF2α. The ED50 value for 13,14-dihydro PGF2α as a luteolytic agent in hamsters is 1.5 µg/100 g.{1795}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • 13,14-dihydro Prostaglandin F2α (13,14-dihydro PGF2α) is the analog of PGF2α which has no unsaturation in the lower side chain. It causes luteolysis in hamsters with a potency five times higher than PGF2α. The ED50 value for 13,14-dihydro PGF2α as a luteolytic agent in hamsters is 1.5 µg/100 g.{1795}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • 13,14-dihydro Prostaglandin F2α (13,14-dihydro PGF2α) is the analog of PGF2α which has no unsaturation in the lower side chain. It causes luteolysis in hamsters with a potency five times higher than PGF2α. The ED50 value for 13,14-dihydro PGF2α as a luteolytic agent in hamsters is 1.5 µg/100 g.{1795}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • PGE2 is metabolized rapidly to 13,14-dihydro-15-keto PGE2, which is present in the plasma of humans and other mammals. 13,14-dihydro-15-keto PGA2 results from the non-enzymatic dehydration of 13,14-dihydro-15-keto PGE2, a process which is accelerated by the presence of albumin.{581,366} Further decomposition of 13,14-dihydro-15-keto PGA2 by the intentional addition of base produces bicyclo PGE2, a stable marker of PGE2 biosynthesis.{366}  

     

    Brand:
    Cayman
    SKU:10260 - 1 mg

    Available on backorder

  • PGE2 is metabolized rapidly to 13,14-dihydro-15-keto PGE2, which is present in the plasma of humans and other mammals. 13,14-dihydro-15-keto PGA2 results from the non-enzymatic dehydration of 13,14-dihydro-15-keto PGE2, a process which is accelerated by the presence of albumin.{581,366} Further decomposition of 13,14-dihydro-15-keto PGA2 by the intentional addition of base produces bicyclo PGE2, a stable marker of PGE2 biosynthesis.{366}  

     

    Brand:
    Cayman
    SKU:10260 - 10 mg

    Available on backorder

  • PGE2 is metabolized rapidly to 13,14-dihydro-15-keto PGE2, which is present in the plasma of humans and other mammals. 13,14-dihydro-15-keto PGA2 results from the non-enzymatic dehydration of 13,14-dihydro-15-keto PGE2, a process which is accelerated by the presence of albumin.{581,366} Further decomposition of 13,14-dihydro-15-keto PGA2 by the intentional addition of base produces bicyclo PGE2, a stable marker of PGE2 biosynthesis.{366}  

     

    Brand:
    Cayman
    SKU:10260 - 5 mg

    Available on backorder

  • Prostaglandin E2 (PGE2; Item Nos. 14010 | 10007211) is metabolized rapidly to 13,14-dihydro-15-keto PGE2 (Item Nos. 14650 | 10007214), which is present in the plasma of humans and other mammals. 13,14-dihydro-15-keto PGA2 results from the non-enzymatic dehydration of 13,14-dihydro-15-keto PGE2, a process which is accelerated by the presence of albumin.{581,366} Further decomposition of 13,14-dihydro-15-keto PGA2 by the intentional addition of base produces bicyclo PGE2 (Item No. 14530), a stable marker of PGE2 biosynthesis.{366} 13,14-dihydro-15-keto PGA2 MaxSpec® standard is a quantitative grade standard of 13,14-dihydro-15-keto PGA2 (Item No. 10260) that has been prepared specifically for mass spectrometry or any application where quantitative reproducibility is required. The solution has been prepared gravimetrically and is supplied in a deactivated glass ampule sealed under argon. The concentration was verified by comparison to an independently prepared calibration standard. This 13,14-dihydro-15-keto PGA2 MaxSpec® standard is guaranteed to meet identity, purity, stability, and concentration specifications and is provided with a batchspecific certificate of analysis. Ongoing stability testing is performed to ensure the concentration remains accurate throughout the shelf life of the product. Note: The amount of solution added to the vial is in excess of the listed amount. Therefore, it is necessary to accurately measure volumes for preparation of calibration standards. Follow recommended storage and handling conditions to maintain product quality.  

     

    Brand:
    Cayman
    SKU:10007200 - 100 µg

    Available on backorder

  • Prostaglandin D1 (PGD1) is the theoretical D-series metabolite of dihomo-γ-linolenic acid (DGLA), but to date it has not been isolated as a natural product. It is an inhibitor of ADP-induced platelet aggregation in humans with an IC50 value of 320 ng/ml, about 1/10 as potent as PGD2.{1139} 13,14-dihydro-15-keto Prostaglandin D1 (13,14-dihydro-15-keto PGD1) is the theoretical metabolite of PGD1 via the 15-hydroxy PG dehydrogenase metabolic pathway. No biological studies for this compound have been reported.  

     

    Brand:
    Cayman
    SKU:10010425 - 1 mg

    Available on backorder

  • Prostaglandin D1 (PGD1) is the theoretical D-series metabolite of dihomo-γ-linolenic acid (DGLA), but to date it has not been isolated as a natural product. It is an inhibitor of ADP-induced platelet aggregation in humans with an IC50 value of 320 ng/ml, about 1/10 as potent as PGD2.{1139} 13,14-dihydro-15-keto Prostaglandin D1 (13,14-dihydro-15-keto PGD1) is the theoretical metabolite of PGD1 via the 15-hydroxy PG dehydrogenase metabolic pathway. No biological studies for this compound have been reported.  

     

    Brand:
    Cayman
    SKU:10010425 - 10 mg

    Available on backorder

  • Prostaglandin D1 (PGD1) is the theoretical D-series metabolite of dihomo-γ-linolenic acid (DGLA), but to date it has not been isolated as a natural product. It is an inhibitor of ADP-induced platelet aggregation in humans with an IC50 value of 320 ng/ml, about 1/10 as potent as PGD2.{1139} 13,14-dihydro-15-keto Prostaglandin D1 (13,14-dihydro-15-keto PGD1) is the theoretical metabolite of PGD1 via the 15-hydroxy PG dehydrogenase metabolic pathway. No biological studies for this compound have been reported.  

     

    Brand:
    Cayman
    SKU:10010425 - 5 mg

    Available on backorder

  • 13,14-dihydro-15-keto Prostaglandin D2 (13,14-dihydro-15-keto PGD2) is a metabolite of PGD2 (Item No. 12010) which is formed through the 15-hydroxy PGDH pathway. 13,14-dihydro-15-keto PGD2 was recently identified as a selective agonist for the CRTH2/DP2 receptor.{5248} It also inhibits ion flux in a canine colonic mucosa preparation.{9769} In humans, 13,14-dihydro-15-keto PGD2 is further metabolized to give 11β-hydroxy compounds which have also undergone β-oxidation of one or both side chains. Virtually no 13,14-dihydro-15-keto PGD2 survives intact in the urine.{418,35}  

     

    Brand:
    Cayman
    SKU:12610 - 1 mg

    Available on backorder

  • 13,14-dihydro-15-keto Prostaglandin D2 (13,14-dihydro-15-keto PGD2) is a metabolite of PGD2 (Item No. 12010) which is formed through the 15-hydroxy PGDH pathway. 13,14-dihydro-15-keto PGD2 was recently identified as a selective agonist for the CRTH2/DP2 receptor.{5248} It also inhibits ion flux in a canine colonic mucosa preparation.{9769} In humans, 13,14-dihydro-15-keto PGD2 is further metabolized to give 11β-hydroxy compounds which have also undergone β-oxidation of one or both side chains. Virtually no 13,14-dihydro-15-keto PGD2 survives intact in the urine.{418,35}  

     

    Brand:
    Cayman
    SKU:12610 - 10 mg

    Available on backorder

  • 13,14-dihydro-15-keto Prostaglandin D2 (13,14-dihydro-15-keto PGD2) is a metabolite of PGD2 (Item No. 12010) which is formed through the 15-hydroxy PGDH pathway. 13,14-dihydro-15-keto PGD2 was recently identified as a selective agonist for the CRTH2/DP2 receptor.{5248} It also inhibits ion flux in a canine colonic mucosa preparation.{9769} In humans, 13,14-dihydro-15-keto PGD2 is further metabolized to give 11β-hydroxy compounds which have also undergone β-oxidation of one or both side chains. Virtually no 13,14-dihydro-15-keto PGD2 survives intact in the urine.{418,35}  

     

    Brand:
    Cayman
    SKU:12610 - 5 mg

    Available on backorder

  • 13,14-dihydro-15-keto Prostaglandin D2 (13,14-dihydro-15-keto PGD2) is a metabolite of PGD2 (Item Nos. 12010 | 10007202) which is formed through the 15-hydroxy PGDH pathway. 13,14-dihydro-15-keto PGD2 was recently identified as a selective agonist for the CRTH2/DP2 receptor.{5248} It also inhibits ion flux in a canine colonic mucosa preparation.{9769} In humans, 13,14-dihydro-15-keto PGD2 is further metabolized to give 11β-hydroxy compounds which have also undergone β-oxidation of one or both side chains. Virtually no 13,14-dihydro-15-keto PGD2 survives intact in the urine.{418,35} 13,14-dihydro-15-keto PGD2 MaxSpec® standard is a quantitative grade standard of 13,14-dihydro-15-keto PGD2 (Item No. 12610) that has been prepared specifically for mass spectrometry or any application where quantitative reproducibility is required. The solution has been prepared gravimetrically and is supplied in a deactivated glass ampule sealed under argon. The concentration was verified by comparison to an independently prepared calibration standard. This 13,14-dihydro-15-keto PGD2 MaxSpec® standard is guaranteed to meet identity, purity, stability, and concentration specifications and is provided with a batch-specific certificate of analysis. Ongoing stability testing is performed to ensure the concentration remains accurate throughout the shelf life of the product. Note: The amount of solution added to the vial is in excess of the listed amount. Therefore, it is necessary to accurately measure volumes for preparation of calibration standards. Follow recommended storage and handling conditions to maintain product quality.  

     

    Brand:
    Cayman
    SKU:10007208 - 100 µg

    Available on backorder

  • 13,14-dihydro-15-keto Prostaglandin E1 (PGE1) is a metabolite of PGE1 with much reduced biological activity.{4383,182,2126} Steady state plasma concentrations are about 10 pg/ml.{4383} 13,14-dihydro-15-keto PGE1 is a weak inhibitor of ADP-induced platelet aggregation in human PRP and washed platelets with IC50 values of 54 and 200 µM, respectively, compared to PGE1 which has an IC50 of 40 nM.{960}  

     

    Brand:
    Cayman
    SKU:-
  • 13,14-dihydro-15-keto Prostaglandin E1 (PGE1) is a metabolite of PGE1 with much reduced biological activity.{4383,182,2126} Steady state plasma concentrations are about 10 pg/ml.{4383} 13,14-dihydro-15-keto PGE1 is a weak inhibitor of ADP-induced platelet aggregation in human PRP and washed platelets with IC50 values of 54 and 200 µM, respectively, compared to PGE1 which has an IC50 of 40 nM.{960}  

     

    Brand:
    Cayman
    SKU:-
  • 13,14-dihydro-15-keto Prostaglandin E1 (PGE1) is a metabolite of PGE1 with much reduced biological activity.{4383,182,2126} Steady state plasma concentrations are about 10 pg/ml.{4383} 13,14-dihydro-15-keto PGE1 is a weak inhibitor of ADP-induced platelet aggregation in human PRP and washed platelets with IC50 values of 54 and 200 µM, respectively, compared to PGE1 which has an IC50 of 40 nM.{960}  

     

    Brand:
    Cayman
    SKU:-
  • 13,14-dihydro-15-keto Prostaglandin E2 (13,14-dihydro-15-keto PGE2) is the primary metabolite of PGE2 (Item No. 14010) in plasma.{182} Endogenous or infused PGE2 is rapidly metabolized by the enzymes 15-hydroxy PGDH and 15-oxo-PG Δ13-reductase to form 13,14-dihydro-15-keto PGE2. 13,14-dihydro-15-keto PGE2 accumulates to detectable levels; plasma levels in humans are between 10-100 pg/ml.{366,433} It undergoes further metabolism and chemical decomposition, giving it a relatively short half-life. In dogs, the plasma half-life of 13,14-dihydro-15-keto PGE2 is about 9 minutes.{433} In humans the metabolite has a similar short half-life, making it a poor choice of analytes for assays designed to measure total PGE2 biosynthesis.{4383,581}  

     

    Brand:
    Cayman
    SKU:-
  • 13,14-dihydro-15-keto Prostaglandin E2 (13,14-dihydro-15-keto PGE2) is the primary metabolite of PGE2 (Item No. 14010) in plasma.{182} Endogenous or infused PGE2 is rapidly metabolized by the enzymes 15-hydroxy PGDH and 15-oxo-PG Δ13-reductase to form 13,14-dihydro-15-keto PGE2. 13,14-dihydro-15-keto PGE2 accumulates to detectable levels; plasma levels in humans are between 10-100 pg/ml.{366,433} It undergoes further metabolism and chemical decomposition, giving it a relatively short half-life. In dogs, the plasma half-life of 13,14-dihydro-15-keto PGE2 is about 9 minutes.{433} In humans the metabolite has a similar short half-life, making it a poor choice of analytes for assays designed to measure total PGE2 biosynthesis.{4383,581}  

     

    Brand:
    Cayman
    SKU:-
  • 13,14-dihydro-15-keto Prostaglandin E2 (13,14-dihydro-15-keto PGE2) is the primary metabolite of PGE2 (Item No. 14010) in plasma.{182} Endogenous or infused PGE2 is rapidly metabolized by the enzymes 15-hydroxy PGDH and 15-oxo-PG Δ13-reductase to form 13,14-dihydro-15-keto PGE2. 13,14-dihydro-15-keto PGE2 accumulates to detectable levels; plasma levels in humans are between 10-100 pg/ml.{366,433} It undergoes further metabolism and chemical decomposition, giving it a relatively short half-life. In dogs, the plasma half-life of 13,14-dihydro-15-keto PGE2 is about 9 minutes.{433} In humans the metabolite has a similar short half-life, making it a poor choice of analytes for assays designed to measure total PGE2 biosynthesis.{4383,581}  

     

    Brand:
    Cayman
    SKU:-
  • 13,14-dihydro-15-keto Prostaglandin E2 (13,14-dihydro-15-keto PGE2) is the primary metabolite of PGE2 (Item Nos. 14010 | 10007211) in plasma.{182} Endogenous or infused PGE2 is rapidly metabolized by the enzymes 15-hydroxy PGDH and 15-oxo-prostaglandin Δ13-reductase to form 13,14-dihydro-15-keto PGE2. 13,14-dihydro-15-keto PGE2 accumulates to detectable levels; plasma levels in humans are between 10-100 pg/ml.{433,4383} It undergoes further metabolism and chemical decomposition, giving it a relatively short half-life. In dogs, the plasma half-life of 13,14-dihydro-15-keto PGE2 is about 9 minutes.{433} In humans the metabolite has a similar short half-life, making it a poor choice of analytes for assays designed to measure total PGE2 biosynthesis.{366,581} 13,14-dihydro-15-keto PGE2 MaxSpec® standard is a quantitative grade standard of 13,14-dihydro-15-keto PGE2 (Item No. 14650) that has been prepared specifically for mass spectrometry or any application where quantitative reproducibility is required. The solution has been prepared gravimetrically and is supplied in a deactivated glass ampule sealed under argon. The concentration was verified by comparison to an independently prepared calibration standard. This 13,14-dihydro-15-keto PGE2 MaxSpec® standard is guaranteed to meet identity, purity, stability, and concentration specifications and is provided with a batchspecific certificate of analysis. Ongoing stability testing is performed to ensure the concentration remains accurate throughout the shelf life of the product. Note: The amount of solution added to the vial is in excess of the listed amount. Therefore, it is necessary to accurately measure volumes for preparation of calibration standards. Follow recommended storage and handling conditions to maintain product quality.  

     

    Brand:
    Cayman
    SKU:10007214 - 100 µg

    Available on backorder

  • 13,14-dihydro-15-keto Prostaglandin F1α (13,14-dihydro-15-keto PGF1α) is a metabolite of PGF1α that has been reported in the rat stomach.{1164} The measurement of 13,14-dihydro-15-keto PGF1α can be used as a marker of the in vivo production of PGF1α.{2106}  

     

    Brand:
    Cayman
    SKU:-
  • 13,14-dihydro-15-keto Prostaglandin F1α (13,14-dihydro-15-keto PGF1α) is a metabolite of PGF1α that has been reported in the rat stomach.{1164} The measurement of 13,14-dihydro-15-keto PGF1α can be used as a marker of the in vivo production of PGF1α.{2106}  

     

    Brand:
    Cayman
    SKU:-
  • 13,14-dihydro-15-keto Prostaglandin F1α (13,14-dihydro-15-keto PGF1α) is a metabolite of PGF1α that has been reported in the rat stomach.{1164} The measurement of 13,14-dihydro-15-keto PGF1α can be used as a marker of the in vivo production of PGF1α.{2106}  

     

    Brand:
    Cayman
    SKU:-
  • 13,14-dihydro-15-keto Prostaglandin F1α (13,14-dihydro-15-keto PGF1α) is a metabolite of PGF1α that has been reported in the rat stomach.{1164} The measurement of 13,14-dihydro-15-keto PGF1α can be used as a marker of the in vivo production of PGF1α.{2106}  

     

    Brand:
    Cayman
    SKU:-
  • 13,14-dihydro-15-keto Prostaglandin F2α (13,14-dihydro-15-keto PGF2α) is the first prominent plasma metabolite of PGF2α in the 15-hydroxy PGDH pathway.{187} Measurement of 13,14-dihydro-15-keto PGF2α in plasma can be used as a marker of the in vivo production of PGF2α.{187,1463,878}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • 13,14-dihydro-15-keto Prostaglandin F2α (13,14-dihydro-15-keto PGF2α) is the first prominent plasma metabolite of PGF2α in the 15-hydroxy PGDH pathway.{187} Measurement of 13,14-dihydro-15-keto PGF2α in plasma can be used as a marker of the in vivo production of PGF2α.{187,1463,878}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • 13,14-dihydro-15-keto Prostaglandin F2α (13,14-dihydro-15-keto PGF2α) is the first prominent plasma metabolite of PGF2α in the 15-hydroxy PGDH pathway.{187} Measurement of 13,14-dihydro-15-keto PGF2α in plasma can be used as a marker of the in vivo production of PGF2α.{187,1463,878}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Brand:
    Cayman
    SKU:416672 - 100 dtn

    Available on backorder

  • Brand:
    Cayman
    SKU:416672 - 500 dtn

    Available on backorder

  • Prostaglandin F2α (PGF2α) is one of the five primary prostaglandins derived enzymatically directly from the endoperoxide PGH2. PGF2α was initially discovered in seminal fluid, and to date the majority of the functional roles ascribed to it relate to fertility, pregnancy, and parturition. PGF2α is a potent luteolytic agent and is used to induce ovulation in domestic livestock. It is also a potent uterine stimulant, and is part of the cascade of myometrial stimulants which induce and sustain labor. PGF2α is rapidly metabolized to 13,14-dihydro-15-keto PGF2α in vivo, by the enzymes 15-hydroxy prostaglandin dehydrogenase and Δ13-reductucase.{310,1157,5442,387} Measurement of 13,14-dihydro-15-keto PGF2α in plasma can be used as a marker of the in vivo production of PGF2α.{878,1463} The Cayman Chemical 13,14-dihydro-15-keto PGF2α Enzyme Immunoassay is a competitive assay that provides measurements of 13,14-dihydro-15-keto PGF2α within the range of 2.3-5,000 pg/ml, typically with a detection limit (80% B/B0) of approximately 15 pg/ml. Although the tracer and antiserum for this assay have been sold separately for many years, the reagents are now combined with an accurate standard and packaged together in a convenient assay kit. The assay has been validated for the measurement of 13,14-dihydro-15-keto PGF2α in plasma, a common matrix for measurement of this PGF2α metabolite.{878}  

     

    Brand:
    Cayman
    SKU:516671 - 480 solid wells

    Available on backorder

  • Prostaglandin F2α (PGF2α) is one of the five primary prostaglandins derived enzymatically directly from the endoperoxide PGH2. PGF2α was initially discovered in seminal fluid, and to date the majority of the functional roles ascribed to it relate to fertility, pregnancy, and parturition. PGF2α is a potent luteolytic agent and is used to induce ovulation in domestic livestock. It is also a potent uterine stimulant, and is part of the cascade of myometrial stimulants which induce and sustain labor. PGF2α is rapidly metabolized to 13,14-dihydro-15-keto PGF2α in vivo, by the enzymes 15-hydroxy prostaglandin dehydrogenase and Δ13-reductucase.{310,1157,5442,387} Measurement of 13,14-dihydro-15-keto PGF2α in plasma can be used as a marker of the in vivo production of PGF2α.{878,1463} The Cayman Chemical 13,14-dihydro-15-keto PGF2α Enzyme Immunoassay is a competitive assay that provides measurements of 13,14-dihydro-15-keto PGF2α within the range of 2.3-5,000 pg/ml, typically with a detection limit (80% B/B0) of approximately 15 pg/ml. Although the tracer and antiserum for this assay have been sold separately for many years, the reagents are now combined with an accurate standard and packaged together in a convenient assay kit. The assay has been validated for the measurement of 13,14-dihydro-15-keto PGF2α in plasma, a common matrix for measurement of this PGF2α metabolite.{878}  

     

    Brand:
    Cayman
    SKU:516671 - 480 strip wells

    Available on backorder

  • Prostaglandin F2α (PGF2α) is one of the five primary prostaglandins derived enzymatically directly from the endoperoxide PGH2. PGF2α was initially discovered in seminal fluid, and to date the majority of the functional roles ascribed to it relate to fertility, pregnancy, and parturition. PGF2α is a potent luteolytic agent and is used to induce ovulation in domestic livestock. It is also a potent uterine stimulant, and is part of the cascade of myometrial stimulants which induce and sustain labor. PGF2α is rapidly metabolized to 13,14-dihydro-15-keto PGF2α in vivo, by the enzymes 15-hydroxy prostaglandin dehydrogenase and Δ13-reductucase.{310,1157,5442,387} Measurement of 13,14-dihydro-15-keto PGF2α in plasma can be used as a marker of the in vivo production of PGF2α.{878,1463} The Cayman Chemical 13,14-dihydro-15-keto PGF2α Enzyme Immunoassay is a competitive assay that provides measurements of 13,14-dihydro-15-keto PGF2α within the range of 2.3-5,000 pg/ml, typically with a detection limit (80% B/B0) of approximately 15 pg/ml. Although the tracer and antiserum for this assay have been sold separately for many years, the reagents are now combined with an accurate standard and packaged together in a convenient assay kit. The assay has been validated for the measurement of 13,14-dihydro-15-keto PGF2α in plasma, a common matrix for measurement of this PGF2α metabolite.{878}  

     

    Brand:
    Cayman
    SKU:516671 - 96 solid wells

    Available on backorder

  • Prostaglandin F2α (PGF2α) is one of the five primary prostaglandins derived enzymatically directly from the endoperoxide PGH2. PGF2α was initially discovered in seminal fluid, and to date the majority of the functional roles ascribed to it relate to fertility, pregnancy, and parturition. PGF2α is a potent luteolytic agent and is used to induce ovulation in domestic livestock. It is also a potent uterine stimulant, and is part of the cascade of myometrial stimulants which induce and sustain labor. PGF2α is rapidly metabolized to 13,14-dihydro-15-keto PGF2α in vivo, by the enzymes 15-hydroxy prostaglandin dehydrogenase and Δ13-reductucase.{310,1157,5442,387} Measurement of 13,14-dihydro-15-keto PGF2α in plasma can be used as a marker of the in vivo production of PGF2α.{878,1463} The Cayman Chemical 13,14-dihydro-15-keto PGF2α Enzyme Immunoassay is a competitive assay that provides measurements of 13,14-dihydro-15-keto PGF2α within the range of 2.3-5,000 pg/ml, typically with a detection limit (80% B/B0) of approximately 15 pg/ml. Although the tracer and antiserum for this assay have been sold separately for many years, the reagents are now combined with an accurate standard and packaged together in a convenient assay kit. The assay has been validated for the measurement of 13,14-dihydro-15-keto PGF2α in plasma, a common matrix for measurement of this PGF2α metabolite.{878}  

     

    Brand:
    Cayman
    SKU:516671 - 96 strip wells

    Available on backorder

  • Brand:
    Cayman
    SKU:416674 - 1 ea

    Available on backorder

  • 13,14-dihydro-15-keto Prostaglandin F2α (13,14-dihydro-15-keto PGF2α) is the first prominent plasma metabolite of PGF2α (Item Nos. 16010 | 10007221) in the 15-hydroxy PGDH pathway.{187} Measurement of 13,14-dihydro-15-keto PGF2α in plasma can be used as a marker of the in vivo production of PGF2α.{187,1463,878} 13,14-dihydro-15-keto PGF2α MaxSpec® standard is a quantitative grade standard of 13,14-dihydro-15-keto PGF2α (Item No. 16670) that has been prepared specifically for mass spectrometry or any application where quantitative reproducibility is required. The solution has been prepared gravimetrically and is supplied in a deactivated glass ampule sealed under argon. The concentration was verified by comparison to an independently prepared calibration standard. This 13,14-dihydro-15-keto PGF2α MaxSpec® standard is guaranteed to meet identity, purity, stability, and concentration specifications and is provided with a batchspecific certificate of analysis. Ongoing stability testing is performed to ensure the concentration remains accurate throughout the shelf life of the product. Note: The amount of solution added to the vial is in excess of the listed amount. Therefore, it is necessary to accurately measure volumes for preparation of calibration standards. Follow recommended storage and handling conditions to maintain product quality.  

     

    Brand:
    Cayman
    SKU:10007226 - 100 µg

    Available on backorder

  • 13,14-dihydro-15-keto Prostaglandin F2α-d4 (13,14-dihydro-15-keto PGF2α-d4) contains four deuterium atoms at the 3, 3′, 4, and 4′ positions. It is intended for use as an internal standard for the quantification of 13,14-dihydro-15-keto PGF2α by GC- or LC-mass spectrometry. 13,14-dihydro-15-keto PGF2α is the first prominent plasma metabolite of PGF2α in the 15-hydroxy PGDH pathway.{187} Measurement of 13,14-dihydro-15-keto PGF2α in plasma can be used as a marker of the in vivo production of PGF2α.{187,878,1463}  

     

    Brand:
    Cayman
    SKU:10007793 - 100 µg

    Available on backorder

  • 13,14-dihydro-15-keto Prostaglandin F2α-d4 (13,14-dihydro-15-keto PGF2α-d4) contains four deuterium atoms at the 3, 3′, 4, and 4′ positions. It is intended for use as an internal standard for the quantification of 13,14-dihydro-15-keto PGF2α by GC- or LC-mass spectrometry. 13,14-dihydro-15-keto PGF2α is the first prominent plasma metabolite of PGF2α in the 15-hydroxy PGDH pathway.{187} Measurement of 13,14-dihydro-15-keto PGF2α in plasma can be used as a marker of the in vivo production of PGF2α.{187,878,1463}  

     

    Brand:
    Cayman
    SKU:10007793 - 50 µg

    Available on backorder

  • 13,14-dihydro-15-keto Prostaglandin F2α-d4 (13,14-dihydro-15-keto PGF2α-d4) contains four deuterium atoms at the 3, 3′, 4, and 4′ positions. It is intended for use as an internal standard for the quantification of 13,14-dihydro-15-keto PGF2α by GC- or LC-mass spectrometry. 13,14-dihydro-15-keto PGF2α is the first prominent plasma metabolite of PGF2α in the 15-hydroxy PGDH pathway.{187} Measurement of 13,14-dihydro-15-keto PGF2α in plasma can be used as a marker of the in vivo production of PGF2α.{187,878,1463}  

     

    Brand:
    Cayman
    SKU:10007793 - 500 µg

    Available on backorder

  • A common metabolic pathway for several prostaglandins (PGs), including PGD2, involves the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs. The removal of four carbons at the α-terminus and oxidation of the terminal ω-carbon produces the abundant urinary metabolites, including tetranor-PGDM.{15162} 13,14-dihydro-15-keto-tetranor PGD2 is a potential metabolite of PGD2. It would be produced from the known metabolite 13,14-dihydro-15-keto PGD2 (Item No. 12610), which is a known agonist for the CRTH2/DP2 receptor.{5248}  

     

    Brand:
    Cayman
    SKU:-
  • A common metabolic pathway for several prostaglandins (PGs), including PGD2, involves the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs. The removal of four carbons at the α-terminus and oxidation of the terminal ω-carbon produces the abundant urinary metabolites, including tetranor-PGDM.{15162} 13,14-dihydro-15-keto-tetranor PGD2 is a potential metabolite of PGD2. It would be produced from the known metabolite 13,14-dihydro-15-keto PGD2 (Item No. 12610), which is a known agonist for the CRTH2/DP2 receptor.{5248}  

     

    Brand:
    Cayman
    SKU:-
  • A common metabolic pathway for several prostaglandins (PGs), including PGD2, involves the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs. The removal of four carbons at the α-terminus and oxidation of the terminal ω-carbon produces the abundant urinary metabolites, including tetranor-PGDM.{15162} 13,14-dihydro-15-keto-tetranor PGD2 is a potential metabolite of PGD2. It would be produced from the known metabolite 13,14-dihydro-15-keto PGD2 (Item No. 12610), which is a known agonist for the CRTH2/DP2 receptor.{5248}  

     

    Brand:
    Cayman
    SKU:-
  • A common metabolic pathway for several prostaglandins (PGs), including PGD2, involves the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs. The removal of four carbons at the α-terminus and oxidation of the terminal ω-carbon produces the abundant urinary metabolites, including tetranor-PGDM.{15162} 13,14-dihydro-15-keto-tetranor PGD2 is a potential metabolite of PGD2. It would be produced from the known metabolite 13,14-dihydro-15-keto PGD2 (Item No. 12610), which is a known agonist for the CRTH2/DP2 receptor.{5248}  

     

    Brand:
    Cayman
    SKU:-
  • A common metabolic pathway for several prostaglandins (PG), including PGE2, involves the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs. The removal of four carbons at the α-terminus and oxidation of the terminal ω-carbon produces the abundant urinary metabolites, including tetranor PGEM.{2127} 13,14-dihydro-15-keto tetranor PGE2 is a potential metabolite of PGE2. It would be produced from the known metabolite 13,14-dihydro-15-keto PGE2 (Item No. 14650), which is known to have a short plasma half-life.{433,366,581}  

     

    Brand:
    Cayman
    SKU:-
  • A common metabolic pathway for several prostaglandins (PG), including PGE2, involves the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs. The removal of four carbons at the α-terminus and oxidation of the terminal ω-carbon produces the abundant urinary metabolites, including tetranor PGEM.{2127} 13,14-dihydro-15-keto tetranor PGE2 is a potential metabolite of PGE2. It would be produced from the known metabolite 13,14-dihydro-15-keto PGE2 (Item No. 14650), which is known to have a short plasma half-life.{433,366,581}  

     

    Brand:
    Cayman
    SKU:-
  • A common metabolic pathway for several prostaglandins (PG), including PGE2, involves the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs. The removal of four carbons at the α-terminus and oxidation of the terminal ω-carbon produces the abundant urinary metabolites, including tetranor PGEM.{2127} 13,14-dihydro-15-keto tetranor PGE2 is a potential metabolite of PGE2. It would be produced from the known metabolite 13,14-dihydro-15-keto PGE2 (Item No. 14650), which is known to have a short plasma half-life.{433,366,581}  

     

    Brand:
    Cayman
    SKU:-
  • The metabolism of F series prostaglandins (PGs), including PGF1α and PGF2α, commonly begins with the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs. The removal of four carbons at the α-terminus and oxidation of the terminal ω carbon produces the abundant urinary metabolites, including tetranor-PGFM.{2128,2129,2130,2131} 13,14-dihydro-15-keto tetranor PGF1α is a potential metabolite of either PGF1α or PGF2α and likely precursor to tetranor-PGFM.  

     

    Brand:
    Cayman
    SKU:-
  • The metabolism of F series prostaglandins (PGs), including PGF1α and PGF2α, commonly begins with the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs. The removal of four carbons at the α-terminus and oxidation of the terminal ω carbon produces the abundant urinary metabolites, including tetranor-PGFM.{2128,2129,2130,2131} 13,14-dihydro-15-keto tetranor PGF1α is a potential metabolite of either PGF1α or PGF2α and likely precursor to tetranor-PGFM.  

     

    Brand:
    Cayman
    SKU:-
  • The metabolism of F series prostaglandins (PGs), including PGF1α and PGF2α, commonly begins with the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs. The removal of four carbons at the α-terminus and oxidation of the terminal ω carbon produces the abundant urinary metabolites, including tetranor-PGFM.{2128,2129,2130,2131} 13,14-dihydro-15-keto tetranor PGF1α is a potential metabolite of either PGF1α or PGF2α and likely precursor to tetranor-PGFM.  

     

    Brand:
    Cayman
    SKU:-
  • 13,14-dihydro-15-keto tetranor-Prostaglandin F1β is a major urinary metabolite of PGE2 that is excreted in guinea pig urine at a concentration range of 1.34-2.74 µg/kg.{111}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • 13,14-dihydro-15-keto tetranor-Prostaglandin F1β is a major urinary metabolite of PGE2 that is excreted in guinea pig urine at a concentration range of 1.34-2.74 µg/kg.{111}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • 13,14-dihydro-15-keto tetranor-Prostaglandin F1β is a major urinary metabolite of PGE2 that is excreted in guinea pig urine at a concentration range of 1.34-2.74 µg/kg.{111}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • 13,14-dihydro-15-keto tetranor-Prostaglandin F1β is a major urinary metabolite of PGE2 that is excreted in guinea pig urine at a concentration range of 1.34-2.74 µg/kg.{111}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • 13,14-dihydro-15(R)-Prostaglandin E1 (13,14-dihydro-15(R)-PGE1) is an analog of 13,14-dihydro-PGE1 (Item No. 13610), which has the hydroxyl group at C-15 in the unnatural R configuration.  

     

    Brand:
    Cayman
    SKU:-
  • 13,14-dihydro-15(R)-Prostaglandin E1 (13,14-dihydro-15(R)-PGE1) is an analog of 13,14-dihydro-PGE1 (Item No. 13610), which has the hydroxyl group at C-15 in the unnatural R configuration.  

     

    Brand:
    Cayman
    SKU:-
  • 13,14-dihydro-15(R)-Prostaglandin E1 (13,14-dihydro-15(R)-PGE1) is an analog of 13,14-dihydro-PGE1 (Item No. 13610), which has the hydroxyl group at C-15 in the unnatural R configuration.  

     

    Brand:
    Cayman
    SKU:-
  • Prostaglandin E1 (PGE1) is produced by the metabolism of dihomo-γ-linolenic acid (DGLA) by the cyclooxygenase pathway. PGE1 inhibits platelet aggregation (IC50 = 40 nM){960,4165} and increases vasodilation. 13,14-dihydro-16,16-difluoro PGE1 is an analog of PGE1. 13,14-dihydro PGE1 is a biologically active metabolite of PGE1, inhibiting platelet aggregation with comparable potency to the parent compound.{2126,4165} The addition of two electron-withdrawing fluorine atoms, which should stabilize the molecule against hydrolytic cleavage, may be expected to delay degradation in vivo.{17623}  

     

    Brand:
    Cayman
    SKU:9000405 - 1 mg

    Available on backorder

  • Prostaglandin E1 (PGE1) is produced by the metabolism of dihomo-γ-linolenic acid (DGLA) by the cyclooxygenase pathway. PGE1 inhibits platelet aggregation (IC50 = 40 nM){960,4165} and increases vasodilation. 13,14-dihydro-16,16-difluoro PGE1 is an analog of PGE1. 13,14-dihydro PGE1 is a biologically active metabolite of PGE1, inhibiting platelet aggregation with comparable potency to the parent compound.{2126,4165} The addition of two electron-withdrawing fluorine atoms, which should stabilize the molecule against hydrolytic cleavage, may be expected to delay degradation in vivo.{17623}  

     

    Brand:
    Cayman
    SKU:9000405 - 100 µg

    Available on backorder

  • Prostaglandin E1 (PGE1) is produced by the metabolism of dihomo-γ-linolenic acid (DGLA) by the cyclooxygenase pathway. PGE1 inhibits platelet aggregation (IC50 = 40 nM){960,4165} and increases vasodilation. 13,14-dihydro-16,16-difluoro PGE1 is an analog of PGE1. 13,14-dihydro PGE1 is a biologically active metabolite of PGE1, inhibiting platelet aggregation with comparable potency to the parent compound.{2126,4165} The addition of two electron-withdrawing fluorine atoms, which should stabilize the molecule against hydrolytic cleavage, may be expected to delay degradation in vivo.{17623}  

     

    Brand:
    Cayman
    SKU:9000405 - 5 mg

    Available on backorder

  • Prostaglandin E1 (PGE1) is produced by the metabolism of dihomo-γ-linolenic acid (DGLA) by the cyclooxygenase pathway. PGE1 inhibits platelet aggregation (IC50 = 40 nM){960,4165} and increases vasodilation. 13,14-dihydro-16,16-difluoro PGE1 is an analog of PGE1. 13,14-dihydro PGE1 is a biologically active metabolite of PGE1, inhibiting platelet aggregation with comparable potency to the parent compound.{2126,4165} The addition of two electron-withdrawing fluorine atoms, which should stabilize the molecule against hydrolytic cleavage, may be expected to delay degradation in vivo.{17623}  

     

    Brand:
    Cayman
    SKU:9000405 - 500 µg

    Available on backorder

  • 13(E)-Docosenoic acid is a 22-carbon monounsaturated fatty acid. It is the trans isomer of 13(Z)-docosenoic acid (Item No. 90175).  

     

    Brand:
    Cayman
    SKU:22580 -

    Out of stock

  • 13(E)-Docosenoic acid is a 22-carbon monounsaturated fatty acid. It is the trans isomer of 13(Z)-docosenoic acid (Item No. 90175).  

     

    Brand:
    Cayman
    SKU:22580 -

    Out of stock

  • 13(E)-Docosenoic acid is a 22-carbon monounsaturated fatty acid. It is the trans isomer of 13(Z)-docosenoic acid (Item No. 90175).  

     

    Brand:
    Cayman
    SKU:22580 -

    Out of stock

  • 13(E)-Docosenoic acid is a 22-carbon monounsaturated fatty acid. It is the trans isomer of 13(Z)-docosenoic acid (Item No. 90175).  

     

    Brand:
    Cayman
    SKU:22580 -

    Out of stock

  • 13(R)-HODE is the opposite enantiomer of the 13(S)-HODE produced when linoleic acid is incubated with soybean lipoxygenase. The presence of 13(R)-HODE in the supernatants and membranes of cultured bovine endothelial cells has been attributed to COX metabolism.{2369} 13(R)-HODE is a weak (IC50 = 2.7 µM) inhibitor of U-46619-induced platelet aggregation.{2365}  

     

    Brand:
    Cayman
    SKU:38605 - 100 µg

    Available on backorder

  • 13(R)-HODE is the opposite enantiomer of the 13(S)-HODE produced when linoleic acid is incubated with soybean lipoxygenase. The presence of 13(R)-HODE in the supernatants and membranes of cultured bovine endothelial cells has been attributed to COX metabolism.{2369} 13(R)-HODE is a weak (IC50 = 2.7 µM) inhibitor of U-46619-induced platelet aggregation.{2365}  

     

    Brand:
    Cayman
    SKU:38605 - 25 µg

    Available on backorder

  • 13(R)-HODE is the opposite enantiomer of the 13(S)-HODE produced when linoleic acid is incubated with soybean lipoxygenase. The presence of 13(R)-HODE in the supernatants and membranes of cultured bovine endothelial cells has been attributed to COX metabolism.{2369} 13(R)-HODE is a weak (IC50 = 2.7 µM) inhibitor of U-46619-induced platelet aggregation.{2365}  

     

    Brand:
    Cayman
    SKU:38605 - 250 µg

    Available on backorder

  • 13(R)-HODE is the opposite enantiomer of the 13(S)-HODE produced when linoleic acid is incubated with soybean lipoxygenase. The presence of 13(R)-HODE in the supernatants and membranes of cultured bovine endothelial cells has been attributed to COX metabolism.{2369} 13(R)-HODE is a weak (IC50 = 2.7 µM) inhibitor of U-46619-induced platelet aggregation.{2365}  

     

    Brand:
    Cayman
    SKU:38605 - 50 µg

    Available on backorder

  • 13(R)-HODE cholesteryl ester was originally extracted from atherosclerotic lesions.{2227} It remains uncertain whether the oxidized fatty acid portion of the molecule results from enzymatic lipoxygenation or from random lipid peroxidation.{1126} 13(R)-HODE cholesteryl ester can be used as a standard for analysis of chiral HODE cholesteryl esters.  

     

    Brand:
    Cayman
    SKU:38606 - 100 µg

    Available on backorder

  • 13(R)-HODE cholesteryl ester was originally extracted from atherosclerotic lesions.{2227} It remains uncertain whether the oxidized fatty acid portion of the molecule results from enzymatic lipoxygenation or from random lipid peroxidation.{1126} 13(R)-HODE cholesteryl ester can be used as a standard for analysis of chiral HODE cholesteryl esters.  

     

    Brand:
    Cayman
    SKU:38606 - 25 µg

    Available on backorder

  • 13(R)-HODE cholesteryl ester was originally extracted from atherosclerotic lesions.{2227} It remains uncertain whether the oxidized fatty acid portion of the molecule results from enzymatic lipoxygenation or from random lipid peroxidation.{1126} 13(R)-HODE cholesteryl ester can be used as a standard for analysis of chiral HODE cholesteryl esters.  

     

    Brand:
    Cayman
    SKU:38606 - 50 µg

    Available on backorder

  • 13(S)-HODE is produced by incubation of linoleic acid with plant and mammalian lipoxygenases. It has been shown to inhibit the adhesion of tumor cells to the endothelium at concentrations around 1 µM,{592,880} and down regulates the expression of the IRGpIIb/IIIa receptor.{591}  

     

    Brand:
    Cayman
    SKU:38610 - 100 µg

    Available on backorder

  • 13(S)-HODE is produced by incubation of linoleic acid with plant and mammalian lipoxygenases. It has been shown to inhibit the adhesion of tumor cells to the endothelium at concentrations around 1 µM,{592,880} and down regulates the expression of the IRGpIIb/IIIa receptor.{591}  

     

    Brand:
    Cayman
    SKU:38610 - 25 µg

    Available on backorder

  • 13(S)-HODE is produced by incubation of linoleic acid with plant and mammalian lipoxygenases. It has been shown to inhibit the adhesion of tumor cells to the endothelium at concentrations around 1 µM,{592,880} and down regulates the expression of the IRGpIIb/IIIa receptor.{591}  

     

    Brand:
    Cayman
    SKU:38610 - 250 µg

    Available on backorder

  • 13(S)-HODE is produced by incubation of linoleic acid with plant and mammalian lipoxygenases. It has been shown to inhibit the adhesion of tumor cells to the endothelium at concentrations around 1 µM,{592,880} and down regulates the expression of the IRGpIIb/IIIa receptor.{591}  

     

    Brand:
    Cayman
    SKU:38610 - 50 µg

    Available on backorder

  • 13(S)-HODE cholesteryl ester was originally extracted from atherosclerotic lesions.{2227} It remains uncertain whether the oxidized fatty acid portion of the molecule results from enzymatic lipoxygenation or from random lipid peroxidation.{1126} 13(S)-HODE cholesteryl ester can be used as a standard for analysis of chiral HODE cholesteryl esters.  

     

    Brand:
    Cayman
    SKU:38611 - 100 µg

    Available on backorder